ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway.
Shen YL, Jiang YP, Li XQ, Wang SJ, Ma MH, Zhang CY, Zhu JY, Rahman K, Zhang LJ, Luan X, Zhang H.
Shen YL, et al. Among authors: zhang cy, zhang lj, zhang h.
Front Pharmacol. 2020 Jan 24;10:1596. doi: 10.3389/fphar.2019.01596. eCollection 2019.
Front Pharmacol. 2020.
PMID: 32038260
Free PMC article.
Retracted.